1023 related articles for article (PubMed ID: 19260501)
1. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
2. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
Xin XM; Li GQ; Jin YY; Zhuang M; Li D
World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
[TBL] [Abstract][Full Text] [Related]
3. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
4. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice.
Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y
Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857
[TBL] [Abstract][Full Text] [Related]
5. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
6. Study of the efficacy of combination therapy of SiRNAs in HepG2.2.15 cells.
Li GQ; Yu DM; Lu J; Chen SL; Zhao JY; Wang YC
Hepatogastroenterology; 2011; 58(106):570-4. PubMed ID: 21661433
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV].
Liang WF; Liu ZH; Yang J; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1374-5. PubMed ID: 17884782
[TBL] [Abstract][Full Text] [Related]
8. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study].
Liu SA; Wei HS; Dong QM; Guo JJ; Qin J; Zhang QY; Liu ZY; Yan J; Cheng J
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3079-83. PubMed ID: 16324412
[TBL] [Abstract][Full Text] [Related]
10. [Specific small interfering RNAs inhibit replication of hepatitis B virus].
Jiao J; Cao H; Zhou MJ; Liu ZH; Ding ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):465-7. PubMed ID: 17545032
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
Konishi M; Wu CH; Wu GY
Hepatology; 2003 Oct; 38(4):842-50. PubMed ID: 14512871
[TBL] [Abstract][Full Text] [Related]
12. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
14. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
15. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
16. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
[TBL] [Abstract][Full Text] [Related]
17. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA.
Ren GL; Bai XF; Zhang Y; Chen HM; Huang CX; Wang PZ; Li GY; Zhang Y; Lian JQ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1051-9. PubMed ID: 16111658
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of hepatitis B virus by combined siRNAs in vitro].
Ye JJ; Xu ZF; Chen Z; Cao J; Zheng S; Ding JY
Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):141-7. PubMed ID: 16011247
[TBL] [Abstract][Full Text] [Related]
19. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
Xu J; Wang J; Deng F; Hu Z; Wang H
Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
[TBL] [Abstract][Full Text] [Related]
20. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]